On August 28, 2019 Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, reported that Jounce management will present at three upcoming investor conferences in September (Press release, Jounce Therapeutics, AUG 28, 2019, View Source [SID1234539059]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Baird 2019 Global Healthcare Conference at 2:35 p.m. ET on Wednesday, September 4, 2019 in New York, NY
2019 Wells Fargo Healthcare Conferenceat 1:20 p.m. ET on Thursday, September 5, 2019 in Boston, MA
H.C. Wainwright 21st Annual Healthcare Conference at 9:10 a.m. ET on Monday, September 9, 2019 in New York, NY
A live webcast of each presentation will be available by visiting "Events & Presentations" in the Investors and Media section of Jounce’s website at www.jouncetx.com. A replay of each webcast will be archived for 30 days following the presentations.